Docetaxel, Ifosfamide, Metabolites, Pharmacokinetics, Phase I.
dx.doi.org/10.1097/00000421-200008000-00010, hdl.handle.net/1765/63627
American Journal of Clinical Oncology
Department of Medical Oncology

Schrijvers, D, Pronk, L.C, Highley, M.S, Bruno, R, Locci-Tonelli, D, de Bruijn, E.A, … Verweij, J. (2000). Pharmacokinetics of ifosfamide are changed by combination with docetaxel: Results of a phase I pharmacologic study. American Journal of Clinical Oncology, 23(4), 358–363. doi:10.1097/00000421-200008000-00010